# Treatment of Strongyloides Infection

> **NCT03605758** · PHASE3 · TERMINATED · sponsor: **Albert Einstein College of Medicine** · enrollment: 51 (actual)

## Conditions studied

- Strongyloides Stercoralis Infection
- Strongyloidiasis

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT03605758
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2015-02-05
- **Final completion:** 2015-02-05
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** The original study PI passed away. Primary and Study Completion dates revised to reflect last participant examination date.
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03605758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03605758, "Treatment of Strongyloides Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03605758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*